Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

Canagliflozin

canagliflozin
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Invokana TABLET, ORAL 100 mg, 300 mg      
VIEW MORE Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
CLASS
682018
Comments:

Invokana medication guide

Automatic renal adjustment to 100 mg daily if eGFR is between 45-60 mL/min. If eGFR less than 45 mL/min, contact the physician to discuss discontinuation and alternative therapy options.

Reviewed: May 28, 2013 (Invokana)

Last updated: Mar. 12, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved